|

Glycopyrrolate 21.25 mcg Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1

Indications

  • Chronic Obstructive Pulmonary Disease1
  • COPD1

Dothan, Alabama1 trial

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

SEC Clinical Research, LLC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.